Product Description
| Cat Number | T6047 |
|---|---|
| Category | Biochemical |
| Pack Size | 1EA |
| Description | Ralimetinib dimesylate (LY2228820 dimesylate) is the dimesylate salt form of LY2228820, a tri-substituted imidazole derivative and orally available p38 mitogen-activated protein kinase (MAPK) inhibitor with potential anti-inflammatory and antineoplastic activities. |
| Molecular Weight | 612.74 |
| Purity | 0.9938 |
| Formula | C24H29FN6·2CH4O3S |
| Smiles | CS(O)(=O)=O.CS(O)(=O)=O.CC(C)(C)Cn1c(N)nc2ccc(nc12)-c1[nH]c(nc1-c1ccc(F)cc1)C(C)(C)C |
| Storage | -20 ℃ |
| View Document | |
| Note | This product is for Research Use Only |
Share Item: